Trial Profile
A Phase 1, Double-Blind (Sponsor Open), Randomized, Placebo-Controlled Trial To Evaluate The Effects Of 100 MG Once Daily Of Eplerenone On Serum Aldesterone And Plasma Renin Activity During 10 Days Of Dosing In Healthy Volunteers.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Heart failure; Hypertension
- Focus Pharmacokinetics
- Sponsors Pfizer
- 20 Oct 2009 Additional location identified as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 12 Oct 2009 New trial record